<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:8pt Arial, sans-serif; }
 .font2 { font:10pt Arial, sans-serif; }
 .font3 { font:11pt Arial, sans-serif; }
 .font4 { font:10pt Times New Roman, serif; }
 .font5 { font:13pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font5">J.P. Morgan</span></p>
<p><span class="font1">Asia Pacific Equity Research</span></p>
<p><span class="font0" style="font-weight:bold;">31 August 2015</span></p>
<p><span class="font0" style="font-weight:bold;">Leon Chik, CFA</span></p>
<p><span class="font0" style="font-weight:bold;">(852) 2800-8590</span></p>
<p><a href="mailto:leon.hk.chik@jpmorgan.com"><span class="font0" style="font-weight:bold;">leon.hk.chik@jpmorgan.com</span></a></p><a name="caption1"></a>
<h5><a name="bookmark0"></a><span class="font2" style="font-weight:bold;"><a name="bookmark1"></a>Highlights from analysts briefing</span></h5>
<ul style="list-style:none;"><li>
<p><span class="font1" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Looking for large market share for amino acids. </span><span class="font4">After current planned capacity increases for high end amino acids, FF aims to be the largest producer (by volume) globally (similar to MSG and Xanthum Gum) within a couple of years. The key to margins is the migration to higher priced amino acids used in the health care and cosmetic industries.</span></p></li>
<li>
<p><span class="font1" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;MSG market remains healthy. </span><span class="font4">Demand for MSG is driven by stable consumer demand for this product. In addition, FF has removed 5-6 percent of its capacity in 2H14 which helps overall pricing power. However prices may not rise in 2H15 because the cost of com may fall. The price of com in China is nearly double that of the price in the USA and there is significant pressure for prices to fall in China. FF says that even if the cost of com and the price of MSG fell, GPM for MSG should remain at a healthy level. GPM for the amino acid division (mostly MSG and other byproducts) improved to 15.7% in 1H15 (12.9% in 1H14) and we expect this division to achieve a 17.5% GPM in 2H15.</span></p></li>
<li>
<p><span class="font1" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Xanthum Gum was the main drag in first half. </span><span class="font4">The ASP and GPM of XG fell in 1H15 due to a drop in demand from the oil and gas industry as well as more supply from competitors (who are most likely loss making at prevailing prices at the end of 1H15. Management is seeing a bottoming of margins at the end of 1H15 and we expect 2H15 GPM for Xanthum Gum to fall to 36% in 2H15 and then 34% for 2016. Fufeng continue to produce more Xanthum gum than it sells as it limits sales (over 13,000 tons added to inventory in 1H15 or about Rmbl40m in value). This is an attempt to stem the decline in prices as Fufeng is the largest producer with about 40- 50% of global sales in 2014. Of course this cannot continue forever and we believe that Fufeng can convert its Xanthum gum lines to produce other products (some amino acids) over the longer term if the market for Xanthum gum remains depressed.</span></p></li></ul>
<table border="1">
<tr><td colspan="6" style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">1H15 results review</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">Interim results (mn)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1H14A</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1H15A</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Growth</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1H15E</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">Variance</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Turnover</span></p></td><td style="vertical-align:top;">
<p><span class="font0">5707</span></p></td><td style="vertical-align:top;">
<p><span class="font0">5631</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-1.3%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">5963</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-5.6%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">Gross profit</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1028</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1037</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">0.9%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">1211</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">-14.4%</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">GPM</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">18.0%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">18.4%</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font0">20.3%</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font0">EBIT</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">530</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">707</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">33.4%</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">714</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0">-1.0%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">Net profit</span></p></td><td style="vertical-align:top;">
<p><span class="font0">275</span></p></td><td style="vertical-align:top;">
<p><span class="font0">414</span></p></td><td style="vertical-align:top;">
<p><span class="font0">50.5%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">447</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-7.6%</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0">EPS</span></p></td><td style="vertical-align:top;">
<p><span class="font0">0.127</span></p></td><td style="vertical-align:top;">
<p><span class="font0">0.186</span></p></td><td style="vertical-align:top;">
<p><span class="font0">45.6%</span></p></td><td style="vertical-align:top;">
<p><span class="font0">0.200</span></p></td><td style="vertical-align:top;">
<p><span class="font0">-7.3%</span></p></td></tr>
</table>
<p><span class="font0">Source: J.P. Morgan estimates; Company data</span></p>
<p><span class="font4">Fufeng reported results which were lower than our expectations driven largely by weakness in the Xanthum gum division. Sales missed our expectations due mainly to the reduction in volume sales of Xanthum gum as Fufeng held back 30% of production as inventory which depressed sales. Sales and gross margin for the new Amino Acid division (MSG + byproducts plus high end amino acids) were largely in line with expectations. GA expenses grew by 6% Y/Y and we had expected this to fall by 5% because Fufeng had managed to cut GA costs by 15% in 2014 Y/Y. The company’s EBIT in 1H15 was lifted by a Rmbl62m gain on disposal of a property in Shandong which we had not anticipated. Factoring in this gain EBIT and NP was not too far from our estimates but we note that core net profit (excluding after tax gain on property disposal) was about 30% lower than our expectations.</span></p>
<p><span class="font0" style="font-weight:bold;">3</span></p>
<p><span class="font3">This document is being provided for the exclusive use of </span><a href="mailto:huzaifa.merchant@jpmorgan.com"><span class="font3">huzaifa.merchant@jpmorgan.com</span></a><span class="font3"> &amp;&nbsp;clients of J.P. Morgan.</span></p>
</body>
</html>